9MW-3011

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug Name9MW-3011
Drug Alias Name9MW30119-MW30119MW-30119-MW-3011MWTx-003 +[11] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTransmembrane protease serine 6 inhibitors
TargetsTransmembrane protease serine 6
Therapy Area/IndicationsIron Overloadbeta-ThalassemiaAnemia, Sickle Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMabwell Therapeutics Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesDisc Medicine IncMabwell (Shanghai) Bioscience Co Ltd
Inactive CompaniesN/A
Active IndicationsIron Overloadbeta-ThalassemiaAnemia, Sickle Cell +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A